FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10645111000001100: Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
36293001000001119 Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43183101000001111 Neo-Fradin 125mg/5ml oral solution (Imported (United States)) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Is a Product containing precisely neomycin sulfate 25 milligram/1 milliliter conventional release oral solution true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has active ingredient Neomycin sulfate false Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has active ingredient Skin anti-infective false Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has excipient Propyl 4-hydroxybenzoate false Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has excipient Methyl 4-hydroxybenzoate false Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has specific active ingredient Neomycin sulfate true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) 480 ml Is pack of False Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Inferred relationship Existential restriction modifier
Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) 480 ml Has AMP True Neo-Fradin 125mg/5ml oral solution (Pharma-Tek) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start